Zusamenfassung
In den westlichen Industrieländern ist das Mammakarzinom der häufigste bösartige Tumor der Frau. Von besonderer Bedeutung ist der seit vielen Jahren in den meisten westlichen Industrienationen verzeichnete Inzidenzanstieg, der in den USA seit den 1940er Jahren im Schnitt 1% pro Jahr betrug und in Deutschland Mitte der 1990er Jahre erstmalig rückläufig war. Über den weiteren Verlauf des langfristigen Trends wird erst die nächste Schätzung Klarheit bringen. Ein Teil der Inzidenzsteigerung ist sicherlich auf die Veränderung des Reproduktionsverhaltens und die damit verlängerte Östrogeneinwirkung auf das undifferenzierte Brustdrüsenparenchym zurückzuführen. Dennoch kann der Anstieg, wie auch die hohe Inzidenz selbst, nur zu etwa 25-30% mit den heute bekannten Risikofaktoren erklärt werden. Daher ist es von besonderer Bedeutung, sich mit den exogenen (Umwelt-) Faktoren auseinander zu setzen, die im Verdacht stehen, eine Rolle bei der Entstehung und Promotion des Brustkrebses zu spielen. Darüber hinaus sind Fragen nach der Ursache von Brusterkrankungen in der Praxis häufig. Die Befähigung, hier Rat geben zu können, wird von den Patientinnen als Kompetenzzuwachs erlebt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alpert M, Carome E et al. (2009) Nighttime use of special spectacles or light bulbs that block blue light may reduce the risk of cancer. Med Hypotheses 73(3): 324–325
Ambrosone CB, Freudenheim JL, Graham S et al. (1995) Cytochrome P450 1 A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer-Res 55(16): 3483–3485
Ambrosone CB, Freudenheim JL, Graham S et al. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276(18): 1494–1501
Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister in Deutschland (1999) Krebs in Deutschland, Häufigkeiten und Trends. 2. Aufl., Robert-Koch-Institut, Berlin
Bailey LB (2003) Folate, methyl-related nutrients, alcohol, and the MTHFR 677C →T-polymorphism affect cancer risk: intake recommendations. J Nutr 133(11): 3748–3753
Bartsch C, Bartsch H, Jain AK, Laaumas KR, Wetterberg L (1981) Uninary melatonin levels in human breast cancer patients. J Neural Transm 52: 269–279
Beniashvili D, Avinoach I, et al. (2005) Household electromagnetic fields and breast cancer in elderly women. In Vivo 19(3): 563–566
Bennicke K, Conrad C, Sabroe S, Sorensen HT (1995) Cigarette smoking and breast cancer. BMJ 310(6992): 1431–1433
Bernhardt JH (1999) Hochfrequente elektromagnetische Felder einschließlich Mikrowellen. In: Mersch-Sundermann V (Hrsg): Umweltmedizin — Grundlagen der Umweltmedizin, klinische Umweltmedizin, ökologische Medizin.Thieme, Stuttgart New York, S 118–126
Bertazzi PA, Pesatori AC, Landi MT (1996) Cancer mortality 1976-1991 in the population exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Organohalogen Compounds 30: 294–297
Birnbaum LS, Fenton SE (2003) Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 111(4): 389–394
Boyd NF, Stone J, et al. (2003) Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 89(9): 1672–1685
Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP (1991) Diet, oncogenesand tumor viruses as modulators of estrogen metabolism in vivo and in vitro. Cancer Prev Dect 16: 35–42
Bradlow HL, Sepkovic DW, Telang NT, Osborne MP (1995) Indole-3-carbinol. A novel approach to breast cancer prevention. Ann N Y Acad Sci 768: 180–200
Bradlow HL, Telang NT, Sepkovic DW, Osborne MP (1996) 2-hydroxyestrone: the‘good’estrogen. J Endocrinol 150: 259–265
Braga C, Negri E, LaVecchia C, Filiberti R, Franceschi S (1996) Cigarette smoking and the risk of breast cancer. Eur J Cancer Prev 5(3): 159–164
Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA (1998) Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19(9): 1623–1629
Calle EE, Frumkin H, Henley SJ, Savitz DA, Thun MJ (2002) Organochlorines and breast cancer risk. CA Cancer J Clin 52(5): 301–309
Cantor KP, Dosemeci M., Brinton LA, Stewart PA (1995) Re: Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 87: 227–228
Caplan LS, Schoenfeld ER, O’Leary E, Leske MC (2000) Breast cancer and electromegnetic fields — a review. AEP 10(1): 31–44
Coogan PF, Aschengrau A (1998) Exposure to power frequency magnetic fields and the risk of breast cancer among female electrical workers in the upper Cape Cod incidence study. Arch Environ Health 53: 359–367
Cook JC, Mullin LS, et al. (1993) Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.Toxicol Appl Pharmacol 119(2): 195–204
Croghan IT, Pruthi S, et al. (2009) The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort. Breast J 15(5): 489–495
Davidson NE (1998) Environmental estrogens and breast cancer risk. Current Opinion in Oncology 10: 475–478
Davis DL, Bradlow HL (1995) Can environmental estrogens cause breast cancer? Scientific American 95(10): 144–149
Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101: 372–376
Demers PA, Thomas DB, Rosenblatt KA et al. (1991) Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 134: 340–347
Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J (1993) High organochlorine body burden in breast cancer women with estrogen receptors. Organohalogen Compounds 13: 385–388
Dunn JF, Nisula B, Rodbard D (1991) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endo Metab 53: 58–64
Emons G, Gründker C, Hanf V (2003) Are estrogens carcinogens? Gynäkologe 36(3): 182–189
Fail PA, Pearce SW, Anderson SA, Tyl RW, Gray E (1995) Endocrine and reproductive toxicity of vinclozolin (vin) in male Long-Evans Hooded rats. Fund Appl Toxicol 15293
Falck F, Ricci A, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyls residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47(2): 143–146
Farlow DW, Xu X, et al. (2009) Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 877(13): 1327–1334
Feychting M, Forssen U (2006) Electromagnetic fields and female breast cancer. Cancer Causes Control 17(4): 553–558
Flesch-Janys D, Berger J, Manz A, Nagel S, Ollroge I (1993) Exposure to polychlorinated dibenzo-p-dioxins and-furans and breast cancer mortality in a cohort of female workers of a herbicide producing plant in Hamburg, FRG. Organohalogen Compounds 13: 381–384
Flodstrom S, Hemming H, Warngard L, Ahlborg UG (1990) Promotion of altered hepatic foci development in rat liver, cytochrome P450 enzyme induction and inhibition of cell-cell communication by DDT and some structurally related organohalogen pesticides. Carcionogenesis 11(8): 1413–1417
Gapstur SM, Potter JD, Drinkard C, Folsom AR (1995) Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 4(4): 313–318
Girgert R, Schimming H, Körner W, et al. (2005) Induction of tamoxifen resistence in breast cancer cells by ELF electromagnetic fields. Biochem Biophys Res Commun 336(4): 1144–1149
Girgert R, Hanf V, etal. (2009a) Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields. Bioelectromagnetics.
Girgert R, Emons G, et al. (2009b) Exposure of mcf-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator system. Int J Gynecol Cancer 19(3): 334–338.
Girgert R, Grundker C, et al. (2008) Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells. Bioelectromagnetics 29(3): 169–176.
Hanf V, Körner W (1999) Gynäkologie Teil 2: Umweltmedizinische Bedeutung endokriner Disruptoren. In: Beyer A, Eis D (Hrsg): Praktische Umweltmedizin — Klinik, Methoden, Arbeitshilfen. Springer, Berlin Heidelberg New York Tokio, S 1–28
Hanf V (2002a) Mammakarzinom und Umweltfaktoren. In: Kreienberg R et al. (Hrsg.): Management des Mammakarzinoms. 2. Aufl. Springer, Berlin, Heidelberg New York Tokio, S 7–32
Hanf V (2002b) Electromagnetic fields and breast cancer — A review. Geburtshilfe und Frauenheilkunde 62(1): 22–29
Hanf V, Gonder U (2005) Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. Eur J Obstet Gynecol Reprod Biol 123(2): 134–149
Hjartaker A, Laake P, et al. (2001) Childhood and adult milk consumption and risk of premenopausal breast cancer in a cohort of 48,844 women — the Norwegian women and cancer study. Int J Cancer 93(6): 888–893
Hunter DJ, Hankinson SE, Laden F, et al. (1997) Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337: 1253–1258
ICRP (1990) Recommendations of the International Commission on Radiological Protection. ICRP publication 60, Annals of the ICRP 21, No. 1-3, Pergamon Press, United Kingdom
Jenkins S, Rowell C, et al. (2007) Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol 23(3): 391–396
Katsouyanni K, Trichopoulou A, Stuver S et al. (1994) Ethanol and breast cancer: an association that may be both confounded and causal. Int J Cancer 58(3): 356–361
Kelce WR, Stone CR, et al. (1995) Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375(6532): 581–585
Kelsh MA, Sahl JD (1997) Mortality among a cohort of electric utility workers 1960-1991. Am J Industr Med 31: 534–544
Knight JA, Bernstein L, et al. (2009) Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women’s Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol 169(8): 962–968
Kociba RJ, Keyes DG, Beyer JE et al. (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxic Appl Pharmac 46: 279–303
Körner W, Hanf V, Faust A, Temmen R, Tinneberg H-R, Hagenmaier H (1994) Concentrations and profiles of PCDDs and PCDFs in human mammary carcinoma tissue. Chemosphere 29(9–11): 2339–2347
Körner W, Hanf V, Schuller W, Bartsch H, Kreienberg R, Hagenmaier H (1996) Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Organohalogen Compounds 27: 297–302
KörnerW, Hanf V, Schuller W, Kempter C, Metzger J, Hagenmaier H (1999) Development of the E-screen assay for sensitive quantitative analysis of estrogenic activity in waste water. Sci Tot Environ 225: 33–48.
Körner W, Vinggaard AM, Térouanne B, Ma R, Wieloch C, Schlumpf M, Sultan C, Soto AM (2004) Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ Health Perspect 112, 695–702
Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N (1994) Breast cancer and serum organochlorides: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86: 589–599
LaVecchia C, Negri E, Parazzini F, Boyle P, Fasoli M, Gentile A, Franceschi S (1989) Alcohol and breast cancer: update from an Italian case-control study. Eur J Cancer Clin Oncol 25(12): 1711–1717
Lamartiniere CA, Moore J, Holland M, Barnes S (1995) Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208: 120–123
Levine PH, Pogo BG, Klouj A, Coronel S, et al. (2004) Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 101(4): 721–726
Li D, Wang M, Dhingra K, Hittelman W-NTI (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer-Res 56(2): 287–293
Li Y, Millikan RC, Bell DA et al. (2004) Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 6(4): 460–473
Liburdy RP, Sloma TR, Sokolic R et al. (1993) ELF magnetic fields, breast cancer and melatonin: 60 Hz fields block melatonin’s oncostatic action on ER+ breast cancer cell proliferation. J Pineal Res 14: 89–97
Liehr JG, Ricci MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci 93(8): 3294–3296
Linet MS, Hatch EE, Kleinerman RA et al. (1997) Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. Engl J Med 337: 44–46
Liu H, Wormke M, Safe SH, Bjeldanes LF (1994) Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86(23): 1758–1765
Lloyd RV, Rosen PP, Sarkar NH etal. (1983) Murine mammary tumor virus related antigen in human male mammary carcinoma. Cancer 51(4): 654–61
Loomis DP, Savitz DA, Ananth CV (1994) Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 86(12): 921–925
López-Carillo L, Blair A, López-Cervantes M et al. (1997) Dichlorodi-phenyltrichloroethane serum levels and breast cancer risk: a case control study from Mexico. Cancer Res 57: 3728–3732
Löscher W, Wahnschaffe U, Mevissen M, Lerchl A, Stamm A (1994) Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats Oncology 51: 288–295
Matanoski GM, Breysse PN, Elliott EA (1991) Electromagnetic field exposure and male breast cancer. Lancet 337: 737
McCready D, Aronson KJ, Chu W, Fan W, Vesprini D, Narod SA (2004) Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada. Cancer Causes Control 15(4): 399–418.
McElroy JA, Egan KM, et al. (2007) Occupational exposure to electromagnetic field and breast cancer risk in a large, populationbased, case-control study in the United States. J Occup Environ Med 49(3): 266–274
McIntyre IM, Norman TR, Burrows GD, Armstrong SM (1989) Human melatonin suppression by light is intensity dependent. J Pineal Res 6: 149–156
Moennikes O, Loeppen S, Buchmann A et al. (2004) A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64(14): 4707–4710
Moorman PG, Terry PD (2004) Consumption of dairy products and the risk of breast cancer: a review of the literature. Am J Clin Nutr 80(1): 5–14
Morabia A, Bernstein M, Heritier S, Khatchatrian N (1996) Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 143(9): 918–928
Mussalo-Rauhamaa H, Häsänen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of Beta-Hexachlorcyclohexane in breast cancer patients. Cancer 66: 2124–2118
Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens Bisphenol A and octylphenol. Environ Health Perspect 105: 70–76
Nagel SC, vom Saal FS, Welshons WV (1999) Developmental effects of estrogenic chemicals are predicted by an in vitro assay incorporating modification of cell uptake by serum. J Steroid Biochem Mol Biol 69: 343–357
O’Leary ES, Vena JE, Freudenheim JL, Brasure J (2004) Pesticide exposure and risk of breast cancer: a nested case-control study of residentially stable women living on Long Island. Environ Res 94(2): 134–144
Osborne MP, Bradlow HL, Wong GY, Telang NT (1993) Upregulation of estradiol C16alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85: 1917–1920
Pollan M, Gustavsson P (1999) High-risk populations for breast cancer in the Swedish female working population. Am J Public Health 89: 875–881
Preston-Martin S (1996) Breast cancer and magnetic fields. Epidemiology 7: 457–458
Pyykkö K, Tuimala R, Aalto L, PerkiöT (1991) Is hydrocarbon hydroxylasea new prognostic indicator for breast cancer? Br J Cancer 63: 596–600
Reichman ME, Judd JT, Longcope C et al. (1993) Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst 85(9): 722–727
Reiter RJ (1985) Action spectra, dose-response relationships, and temporal aspects of light’s effects on the pineal gland. Ann NY Acad Sci 453: 215–230
Rosen baum PF, Vena JE, Zielezny MA, Michalek AM (1994) Occupational exposure associated with male breast cancer. Am J Epidemiol 140: 974–979
Rudel RA, Attfield KR, et al. (2007) Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 109(12 Suppl): 2635–2666
Savitz D (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. Journal of the National Cancer Institute 86: 1255–1256
Schäfer WR, Zahradnik HP, Frijus-Plessen N, Schneider K (1996) Antropogene Substanzen mit unerwünschter Östrogenwirkung: Auswahl von expositions-relevanten Stoffen. Umweltmed Forsch Prax 1: 35–42
Schernhammer E, Schulmeister K (2004) Light at night and cancer risk. Photochem Photobiol 79(4): 316–318
Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. (2001) In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 109: 239–244.
Segal-Eiras A, Croce MV, Pasqualini CD (1983) Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients. Arch Geschwulstforsch 53(4): 321–327
Sonnenschein C, Soto AM (1998) An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Molec Biol 65: 143–150
Soto AM, Chung KL, Sonnenschein C (1994) The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102: 380–383.
Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Olea-Serrano MF (1995): The E-Screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(7): 113–122
Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556–561
Stevens RG (1993) Breast cancer and electric power. Biomed Pharmacother 47(10): 435–438
Stevens RG, Davis S (1996) The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect 104(1): 135–140
Strahlenschutzkommission (1995) Schutz von niederfrequenten elektrischen und magnetischen Feldern der Energieversorgung und-anwendung. Empfehlungen der Strahlenschutzkommission vom 10.5.1995. Bundesanzeiger 47, Nr. 147a, Köln
Vansell NR, Muppidi JR, Habeebu SM, Klaasen CD (2004) Promotion of thyroid tumors in rats by pregnenolone-16-a-carbonitrile (PCN) and polychlorinated biphenyl (PCB). Toxicol Sci. 81(1): 50–59
Verordnung zur Durchführung des Bundesimmissionsschutzgesetzes (1996) Verordnung über elektromagnetische Felder. Bundesgesetzblatt I vom 16.12.1996. http://www.bfs.de/elektro/nff/recht.html
Vinggaard AM, Nellemann C, et al. (2002) Antiandrogenic effects in vitro and in vivo of the fungicide prochloraz. Toxicol Sci 69(2): 344–353
Wassermann M, Nogueira DP, Tomatis L et al. (1976) Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15: 478–484
Westin JB, Richter E (1990) The Israeli Breast-Cancer Anomaly. Ann NY Acad Sci 609: 269–279
Wichmann HE, Schlipköter HW, Fülgraff G (1992) Handbuch der Umweltmedizin. Ecomed-Verlag, Landsberg
Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Canc Inst 85(8): 648–652
Wolff MS, Collmann GW, Barett JC, Huff J (1996) Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 36: 573–596
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg New York
About this chapter
Cite this chapter
Hanf, V., Körner, W. (2010). Mammakarzinom und Umweltfaktoren. In: Mammakarzinom Interdisziplinär. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12681-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-12681-9_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12680-2
Online ISBN: 978-3-642-12681-9
eBook Packages: Medicine (German Language)